Arvid Jungnik und Ingelheim - Info zur Person

(1 - 6 von 7

)

History of Changes for Study: NCT Clinical Trials (.gov)

clinicaltrials.gov

[Recruiting] Biberach, Germany, Contact:Contact: Arvid Jungnik +49 (7351)

Phase I studies of the safety, tolerability, pharmacokinetics ...Diabetes, Obesity and Metabolism

dom-pubs.onlinelibrary.wiley.com

von A Jungnik · · Zitiert von: 8 — Arvid Jungnik MD. Boehringer Ingelheim Pharma GmbH, Biberach, Germany. Search for more papers by this author · Jorge Arrubla Martinez MD,.

Bioequivalence of Linagliptin 5 mg Once Daily docksci.comDOCKSCI.COM

d.docksci.com

— Arvid Jungnik, Silke Retlich, and Thomas Meinicke are employ- ees of Boehringer Ingelheim. Christian Friedrich was an employee.

Safety, tolerability, pharmacokinetics and pharmacodynamics ...Clinical Diabetes and Endocrinology

clindiabetesendo.biomedcentral.com

von S Bianzano · · Zitiert von: 9 — Arvid Jungnik & Corinna Schölch. Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. Cornelia Schepers. Authors. Susanna Bianzano.